Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSupreme Plc Regulatory News (SUP)

Share Price Information for Supreme Plc (SUP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 137.50
Bid: 137.00
Ask: 138.00
Change: 0.00 (0.00%)
Spread: 1.00 (0.73%)
Open: 138.00
High: 138.00
Low: 137.50
Prev. Close: 137.50
SUP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Trading Statement

26 Sep 2023 07:00

RNS Number : 5984N
Supreme PLC
26 September 2023
 

26 September 2023

 

Supreme plc

("Supreme," the "Company" or the "Group")

 

AGM Trading Statement

 

Trading for FY 2024 now expected to be significantly ahead of market expectations1

 

Supreme (AIM:SUP), a leading manufacturer, supplier, and brand owner of fast-moving consumer products, provides an update ahead of its Annual General Meeting ("AGM") at 8.00 a.m. today.

 

At the meeting, Paul McDonald, Chairman of Supreme, will make the following statement:

 

"Supreme traded strongly in the year ended 31 March 2023, delivering significant growth within our vaping activities, alongside solid organic growth across our remaining categories. We have continued to build on this positive momentum in the first half of the current financial year ("H1 2024") and are delighted to report that we remain on track to deliver our strongest financial performance as a listed company.

 

Supreme operates across an extensive customer network within the UK retail space, and, after broadening our already diverse product portfolio and investing in strategic brands, we remain well-positioned to further expand our UK market footprint and capitalise on opportunities within our own, private label and third-party brands.

 

Following record profitable growth in H1 2024, the Company now expects trading for the year ended 31 March 2024 ("FY 2024") to be significantly ahead of market expectations1 with revenue guidance of around £195 - £205 million and Adjusted EBITDA2 guidance of approximately £28 - 30 million, an increase of £3.5 million compared to the market expectations1, with around £2 million of the incremental Adjusted EBITDA2 arising from the Elf opportunity and around £1.5 million incremental Adjusted EBITDA2 arising from the core business. In addition, the investment into working capital to support the Elf opportunity has been managed better than expected and as a result the Company now expects a stronger cash position at half year and year end than initially anticipated.

 

Management now anticipates the contribution of the distribution of Elf and Lost Mary brands across FY 2024, based on current legislation, will be around £4 million of Adjusted EBITDA2 from around £40 million of revenue3.

 

In addition, the continued expansion of our Vaping category remains a key growth driver for Supreme and we continue to attract significant demand for our vaping products from key retailers, with demand across our principal 88Vape brand particularly strong. This increased demand combined with improved margins in our Wellness and Vaping category plus further synergistic overheads savings arising from the businesses acquired in FY23 have led to an increase in the full year Adjusted EBITDA2 expectation for the core business of around £1.5 million.

 

As an industry leader, Supreme acknowledges the wider concerns of youth vaping and remains fully supportive of any proactive measures or changes in legislation that potentially restricts specific products, packaging, flavours or point of sale in the UK.

 

Operationally, we have commenced activities from our new warehousing facility which has already enhanced our distribution and storage, further supporting both our organic and acquisitive growth ambitions.

 

The Board remains pleased with the Group's ongoing financial and operational strategic progress and believes we are ideally positioned to deliver on our medium to long term growth potential."

 

1 Company compiled analyst consensus for the year ending 31 March 2024 prior to release of this announcement was Adjusted EBITDA of £25.6 million.

2 Adjusted EBITDA means operating profit before depreciation, amortisation, share-based payments charge, fair value movements on non-hedge accounted derivatives and exceptional items.

3 Previous guidance for the Elf opportunity was £25 - 30 million of revenue and around £2m of Adjusted EBITDA2.

 

Enquiries:

 

Supreme plc

Sandy Chadha, Chief Executive Officer

Suzanne Smith, Chief Finance Officer

 

via Vigo Consulting

Grant Thornton UK LLP (Nominated Adviser)

Samantha Harrison / Harrison Clarke / Samuel Littler

 

+44 (0)20 7383 5100

Berenberg (Broker)

Mark Whitmore / Marie Moy / Mara Grasso

 

+44 (0)20 3207 7800

Vigo Consulting (Financial Public Relations)

Jeremy Garcia / Kendall Hill

supreme@vigoconsulting.com

+44 (0)20 7390 0230

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 which is part of UK law by virtue of the European Union (withdrawal) Act 2018. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

About Supreme

 

Supreme supplies products across five key categories; batteries, lighting, vaping, sports nutrition & wellness, and branded household consumer goods. The Company's capabilities span from product development and manufacturing through to its extensive retail distribution network and direct to consumer capabilities. This vertically integrated platform provides an excellent route to market for well-known brands and products.

 

The Group has over 3,300 active business accounts with retail customers who manage over 10,000 branded retail outlets. Customers include B&M, Home Bargains, Poundland, Tesco, Sainsburys, Morrisons, Amazon, The Range, Costcutter, Asda, Halfords, Iceland and HM Prison & Probation Service.

 

In addition to distributing globally-recognised brands such as Duracell, Energizer and Panasonic, and supplying lighting products exclusively under the Energizer, Eveready, Black & Decker and JCB licences across 45 countries, Supreme has also developed brands in-house, most notably 88Vape and has a growing footprint in Sports Nutrition and Wellness via its principal brands Sci-MX and Battle Bites.

 

investors.supreme.co.uk/

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMNKPBBDBKBOCB
12
Date   Source Headline
24th Apr 20247:00 amRNSYear End Trading Update
28th Mar 20247:00 amRNSTotal Voting Rights
22nd Mar 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
18th Mar 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
11th Mar 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
4th Mar 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
26th Feb 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
19th Feb 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
6th Feb 20247:00 amRNSCommencement of Share Buyback Programme
29th Jan 20242:42 pmRNSMarket and Trading Update and Share Buyback
5th Jan 20247:00 amRNSAcquisition of protein manufacturing assets
2nd Jan 20247:00 amRNSBlock Admission Return
29th Dec 20237:00 amRNSTotal Voting Rights
1st Dec 20238:58 amRNSGrant of Options and Director Dealing
28th Nov 20237:00 amRNSHalf-year Results
31st Oct 20237:00 amRNSTotal Voting Rights
23rd Oct 20237:00 amRNSAppointment of Nomad and Joint Brokers
18th Oct 20237:01 amRNSVaping Category Update
18th Oct 20237:00 amRNSTrading Statement & Notice of Results
4th Oct 202310:50 amRNSDirector Share Purchase
26th Sep 202312:07 pmRNSResult of AGM
26th Sep 20237:00 amRNSAGM Trading Statement
13th Sep 20238:31 amRNSResponse to Media Speculation
23rd Aug 20237:00 amRNSAvailability of Annual Report & Notice of AGM
5th Jul 20237:01 amRNSSignificant Vaping Distribution Appointment
5th Jul 20237:00 amRNSFinal Results
3rd Jul 20237:00 amRNSBlock Admission of Shares
19th Jun 20239:30 amRNSNotice of Results & Investor Presentation
15th May 20233:07 pmRNSDirector Share Purchase
28th Apr 20237:00 amRNSTotal Voting Rights
20th Apr 202311:56 amRNSHolding(s) in Company
17th Apr 20237:00 amRNSYear End Trading Update
31st Mar 20237:00 amRNSTotal Voting Rights
14th Mar 20232:30 pmRNSDisposal of the IP of T-Juice
28th Feb 202312:34 pmRNSTotal Voting Rights
19th Jan 20237:00 amRNSBlock Admission of Shares
13th Jan 20237:00 amRNSHolding(s) in Company
10th Jan 20232:05 pmRNSSecond Price Monitoring Extn
10th Jan 20232:00 pmRNSPrice Monitoring Extension
10th Jan 20237:00 amRNSStrong Q3 Trading
29th Nov 20227:00 amRNSHalf-year Results
24th Oct 20227:00 amRNSTrading Update and Notice of Results
15th Sep 20225:08 pmRNSResult of AGM
15th Sep 20227:00 amRNSAGM Statement
22nd Aug 202211:06 amRNSSecond Price Monitoring Extn
22nd Aug 202211:00 amRNSPrice Monitoring Extension
15th Aug 20227:00 amRNSAvailability of Annual Report & Notice of AGM
9th Aug 20227:00 amRNSAcquisition of Cuts Ice/Flavour Core trade/assets
8th Aug 20227:00 amRNSGrant of performance share awards to a PDMR
25th Jul 20227:00 amRNSDirector Share Purchase
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.